Science 37 SPAC

Income Statement. In 000's Revenue Total Revenues Y-o-Y Growth Cost of Revenues Gross Profit Gross Margin % General and Adminstrative (ex. Dep/Amort & Stock- based Comp) Adjusted EBITDA Adj. EBITDA Margin % 2019 Actuals Science 37 $14,081 N/A 7,852 $6,229 44% 21,620 ($15,391) -109% 2020 Actuals $23,704 68% 22,597 $1,107 5% 28,157 ($27,050) -114% 2021 Forecast $52,130 120% 35,658 $16,472 32% 65,053 ($48,580) -93% 2022 Forecast $102,253 96% 55,271 $46,982 46% 93,906 ($46,924) -46% 2023 Forecast $182,497 78% 91,208 $91,289 50% 106,688 ($15,399) -8% 2024 Forecast $261,319 43% 120,602 $140,718 54% 125,768 $14,949 6% Adjusted EBITDA is defined as net income, adjusted for: income taxes, depreciation and amortization, interest expense (net), stock-based compensation, other expense/(income), net, restructuring and related charges, and costs associated with this contemplated transaction. 2025 Forecast $362,420 39% 164,690 $197,730 55% 143,031 $54,699 15% 37

View entire presentation